Immunomodulatory Properties of Mesenchymal Stem Cells Can Mitigate Oxidative Stress and Inflammation Process in Human Mustard Lung

Biochemical Genetics

Volumn 54, Issue 6, 2016, Pages 769-783

  Nejad Moghaddam, Amir ^a   Ajdary, Sohiela ^b   Tahmasbpour, Eisa ^a   Rad, Farhad Riazi ^b   Panahi, Yunes ^a   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Adipose derived mesenchymal stem cells; Airway remodeling; Inflammation and oxidative stress genes; Lung epithelial proteins; Sulfur mustard

Indexed keywords

BIOLOGICAL MARKER; CLARA CELL PROTEIN; CLARA CELL PROTEIN 16; FORKHEAD BOX M1; GELATINASE A; GLUTATHIONE; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE REDUCTASE; LACTOPEROXIDASE; MALONALDEHYDE; MATRIX METALLOPEPTIDASE 9; METALLOPEPTIDASE INHIBITOR 1; METALLOPROTEINASE INHIBITOR 2; METALLOTHIONEIN III; MUCIN 1; MUSTARD GAS; OXIDATIVE STRESS RESPONSIVE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; GELATINASE B; MMP9 PROTEIN, HUMAN; SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADIPOSE DERIVED STEM CELL; ARTICLE; CASE REPORT; CELL THERAPY; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; LUNG FUNCTION TEST; LUNG INJURY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; UPREGULATION; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; GENETICS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LUNG DISEASES; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES;

GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, INTRAVENOUS; LUNG DISEASES; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUCIN-1; MUSTARD GAS; OXIDATIVE STRESS; UTEROGLOBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84982803315     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-016-9755-8     Document Type: Article

References (30)

1. Balali-Mood M, Mousavi S, Balali-Mood B (2008) Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans. Emerg Health Threats J 1:e7
2. Beheshti J, Mark EJ, Akbaei HM, Aslani J, Ghanei M (2006) Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202(10):739–744
3. Borgonovo T, Vaz IM, Senegaglia AC, Rebelatto CL, Brofman PR (2014) Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center. Rev Bras Hematol Hemoter 36(3):202–207
4. Chang YS, Ahn SY, Jeon HB, Sung DK, Kim ES, Sung SI, Yoo HS, Choi SJ, Oh WI, Park WS (2014) Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol 51(3):391–399
5. Chen GH, Yang T, Tian H, Qiao M, Liu HW, Fu CC, Miao M, Jin ZM, Tang XW, Han Y, He GS, Zhang XH, Ma X, Chen F, Hu XH, Xue SL, Wang Y, Qiu HY, Sun AN, Chen ZZ, Wu DP (2012) Clinical study of umbilical cord-derived mesenchymal stem cells for treatment of nineteen patients with steroid-resistant severe acute graft-versus-host disease. Zhonghua Xue Ye Xue Za Zhi 33(4):303–306
6. Churg A, Zhou S, Wright JL (2012) Series “matrix metalloproteinases in lung health and disease”: matrix metalloproteinases in COPD. Eur Respir J 39(1):197–209
7. Colagar AH, Pouamir M, Marzony ET, Jorsaraee SGA (2009) Relationship between seminal malondialdehyde and sperm parameters quality in the fertile and infertile men. Braz Arch Biol Technol 52(6):1387–1392
8. Eurlings IM, Dentener MA, Mercken EM, de Cabo R, Bracke KR, Vernooy JH, Wouters EF, Reynaert NL (2014) A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-alpha. Am J Physiol Lung Cell Mol Physiol 307(7):L557–L565
9. Ghanei M, Harandi AA (2011) Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol 23(7):363–371
10. Ghanei M, Akhlaghpoor S, Moahammad MM, Aslani J (2004) Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 16(13):845–849
11. Ghanei M, Khalili AR, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan-Pezeshki M, Panahi Y, Alaeddini F (2005) Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97(5):302–305
12. Ghanei M, Shohrati M, Jafari M, Ghaderi S, Alaeddini F, Aslani J (2008) N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 103(5):428–432
13. Ghanei M, Rajaeinejad M, Motiei-Langroudi R, Alaeddini F, Aslani J (2011) Helium:oxygen versus air:oxygen noninvasive positive-pressure ventilation in patients exposed to sulfur mustard. Heart Lung 40(3):e84–e89
14. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D (2003) Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45(11):1136–1143
15. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, G. Canadian Critical Care Trials (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE 7(10):e47559
16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
17. Morimoto Y, Tsuda T, Nakamura H, Hori H, Yamato H, Nagata N, Higashi T, Kido M, Tanaka I (1997) Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and extracellular matrix mRNA following exposure to mineral fibers and cigarette smoke in vivo. Environ Health Perspect 105(Suppl 5):1247–1251
18. Nejad-Moghaddam A, Panahi Y, Abdollahpour Alitappeh M, Borna H, Shokrgozar MA, Ghanei M (2015) Therapeutic potential of mesenchymal stem cells for the treatment of airway remodeling in pulmonary diseases. Iran J Allergy Asthma Immunol 14(6):552–568
19. Panahi Y, Ghanei M, Aslani J, Mojtahedzadeh M (2005) The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas. Iran J Allergy Asthma Immunol 4(2):83–90
20. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J (1992) Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47(1):25–29
21. Poursaleh Z, Harandi AA, Vahedi E, Ghanei M (2012) Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. Daru 20(1):27
22. Razavi SM, Karbakhsh M, Salamati P (2013) Preventive measures against the mustard gas: a review. Med J Islam Repub Iran 27(2):83–90
23. Tahmasbpour E, Reza Emami S, Ghanei M, Panahi Y (2015) Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection. Inhal Toxicol 27(13):659–672
24. Tahmasbpour E, Ghanei M, Qazvini A, Vahedi E, Panahi Y (2016) Gene expression profile of oxidative stress and antioxidant defense in lung tissue of patients exposed to sulfur mustard. Mutat Res, Genet Toxicol Environ Mutagen 800–801:12–21
25. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27(3):502–522
26. Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, Yamagishi M (2010) Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298(5):H1320–H1329
27. Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N, Dardzinski B, Gritzalis D, Antoniadis A, Froudarakis M, Kolios G, Bouros D (2013) A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med 11:171
28. Van Doren SR (2015) Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol 44–46:224–231
29. Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34(6):747–754
30. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP (2013) A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 143(6):1590–1598